3-(1,3-benzothiazol-2-yl)-7-hydroxy-2H-chromen-2-one(CAS: 58851-99-3)

3-(1,3-benzothiazol-2-yl)-7-hydroxy-2H-chromen-2-one (CAS: 58851-99-3) falls under the scope of various regulatory guidelines such as REACH for its production and importation in the European Union, and the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for its transportation. Additionally, the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have regulations related to its use in pharmaceuticals and environmental releases, respectively.

There are several alternatives to 3-(1,3-benzothiazol-2-yl)-7-hydroxy-2H-chromen-2-one (CAS: 58851-99-3) in synthesis, including 3-(1,3-thiazol-2-yl)-7-hydroxy-2H-chromen-2-one and 3-(1,3-imidazol-2-yl)-7-hydroxy-2H-chromen-2-one. These compounds can serve as effective substitutes due to their similar chemical structures and potential for analogous reactions.

The market for 3-(1,3-benzothiazol-2-yl)-7-hydroxy-2H-chromen-2-one (CAS: 58851-99-3) is closely tied to its applications in pharmaceuticals and research, particularly for its use as an intermediate in the synthesis of certain drugs. Research trends are focusing on its potential in medicinal chemistry and its biological activities, with a growing interest in its role as a scaffold for drug discovery.

Waste containing 3-(1,3-benzothiazol-2-yl)-7-hydroxy-2H-chromen-2-one (CAS: 58851-99-3) should be collected in appropriate containers, labeled, and stored in a secure, well-ventilated area. The waste should then be disposed of through incineration or professional waste disposal services that comply with local regulations. Precautions include avoiding contact with skin and inhalation, and adhering to environmental protection guidelines to prevent contamination of soil and water sources.